All News
Familial Mediterranean Fever mimics
Familial Mediterranean fever (FMF) is an inherited autoinflammatory disease characterized by recurrent attacks of fever and acute inflammation of the membranes lining the abdomen, joints and lungs. These attacks are often short-lasting, around 1-3 days.
Read Article
Gender Differences in Axial Spondyloarthritis
Rheumatic conditions such as SLE and RA exhibit female predominance. In contrast, increasing evidence suggests that gender differences occur in axial spondyloarthritis in terms of time to diagnosis, clinical manifestations, treatment outcomes and quality of life.
Read Article
Dual target blockade may be better than one in SLE
Dr. Yusof ( @Yuz6Yusof) discusses abstracts #L07 and #1001 presented at #ACR22.
https://t.co/20MGDHBLT1 https://t.co/4IcBKn1IKg
Links:
Dr. John Cush RheumNow ( View Tweet)
Repetitive Testing of Anti-dsDNA Antibodies May Predict Flares in SLE
Dr. Sheila Reyes ( @RHEUMarampa ) summarizes abstract #0327 presented during the poster session at #ACR22.
https://t.co/kSFfyRIQXZ https://t.co/bVTE9VsFmC
Links:
Dr. John Cush RheumNow ( View Tweet)
Poor Medication Adherence in SLE and How to Improve It
Dr. Janet Pope ( @Janetbirdope) discusses three abstracts presented at #ACR22.
https://t.co/AWxj4fsTkt https://t.co/Lol1zG7C0q
Links:
Dr. John Cush RheumNow ( View Tweet)
2022 ACR/EULAR Classification Criteria for GCA
Dr. Michael Putman discusses interesting take-home messages from the Vasculitis Investigators Meeting at ACR22 Convergence regarding the 2022 ACR/EULAR Classification Criteria for GCA.
https://t.co/w7NE2Wpm95 https://t.co/vB94wS7ONF
Links:
Dr. John Cush RheumNow ( View Tweet)
To Beta Block or Not in GCA & Large Vessel Vasculitis
Dr. Harkins ( @DrTrishHarkins) discusses abstract 0477 presented at #ACR22.
Abstract 0477: Can Beta-blockers Prevent Aortic Dilation in Patients w/ Giant Cell Arteritis & Large Vessel Vasculitis?
https://t.co/cwA1Z5XrQr https://t.co/QGSS6RUBn3
Links:
Dr. John Cush RheumNow ( View Tweet)
Avoid Abatacept in RA patients with a history of cancer?
Dr. Richard Conway ( @RichardPAConway ) discusses abstracts #0267 and #0255 presented at #ACR22.
https://t.co/t8hun1qfnJ https://t.co/UpuWkk7k3x
Links:
Dr. John Cush RheumNow ( View Tweet)
Professor Georg Schett, MD (University of Erlangen-Nuremberg) presents his novel study of CAR-T cells therapy in Lupus - A MUST look! #ACR22
ACR 2022: CAR-T Cell Treatment of Refractory SLE | VuMedi https://t.co/cpJShTvQDy via @vumedi
Dr. John Cush RheumNow ( View Tweet)
Practical use of JAK inhibitors in select groups in Axial SpA
Dr. Antoni Chan ( @synovialjoints ) talks through select abstracts from #ACR22.
https://t.co/P0JZu8posn https://t.co/u6SSQhZiYb
Links:
Dr. John Cush RheumNow ( View Tweet)
Best of #ACR22 in PsA: Day Three
Dr. Rachel Tate ( @uptoTate) discusses the best PsA content presented on day three (Monday) at ACR22 Convergence in Philadelphia, PA.
https://t.co/NkdaXAMoZE https://t.co/aPnrkYXehz
Links:
Dr. John Cush RheumNow ( View Tweet)
Can Neural Networks Answer Diagnostic Dilemmas in Rheumatology?
Presented at #ACR22, investigators wanted to establish whether neural networks can distinguish seropositive RA+, RA-, and PsA using hand MRI data based on structural inflammation patterns.
https://t.co/X2zceiAQ4J https://t.co/J0VUwlVMze
Links:
Dr. John Cush RheumNow ( View Tweet)
PsA Cycling or Switching MOAs
Dr. Tate ( @uptoTate) interviews Dr. Alexis Ogdie ( @AlexisO) at #ACR22 on Abstract 1600: The Impact of Second-Line Therapeutic on Disease Control After Discontinuation of First Line TNF Inhibitor in Patients with PsA
https://t.co/S83Wbpbd4V https://t.co/B1gTmMAzc1
Links:
Dr. John Cush RheumNow ( View Tweet)
Gender in AxSpa
Dr. Peter Nash ( @drpnash) weighs in at #ACR22.
https://t.co/Utkg4Yltif https://t.co/IvZNe9BQHr
Links:
Dr. John Cush RheumNow ( View Tweet)
Lupus, Sex and STDs
Dr. Kathryn Dao discusses abstract 0939 presented at #ACR22.
https://t.co/4VyRihrpa8 https://t.co/hqsfWeUQQo
Links:
Dr. John Cush RheumNow ( View Tweet)
Frailty in Vasculitis
Dr. Patricia Harkins ( @DrTrishHarkins) sits down with Professor Sebastian Sattui to discuss Abstract 0444, Prevalence of Frailty and Associated Factors in Patients with Vasculitis, being presented on Saturday at #ACR22.
https://t.co/0Gd1cHNVlg https://t.co/blS2XvHIgS
Links:
Dr. John Cush RheumNow ( View Tweet)
Do biologics help taper steroids in Adult Still’s Disease?
A Japanese large scale claims data study presented at #ACR22 (abstract#0826) was able to collect 5-year data to study the treatment patterns in Still’s.
https://t.co/S0HMfWuUai https://t.co/ZKV0aP900w
Links:
Dr. John Cush RheumNow ( View Tweet)
Anifrolumab shows long-term promise in patients with lupus
Researchers report positive results from the first placebo-controlled long-term trial of anifrolumab—a human monoclonal antibody that targets the type I IFN receptor—in patients with lupus.
https://t.co/sYzLMgLzqy https://t.co/fdmhYONI3G
Links:
Dr. John Cush RheumNow ( View Tweet)
Sputum anti-CCP the new diagnostic test in at-risk RA?'
Dr. Aurelie Najm ( @AurelieRheumo) discusses abstract 0533 at #ACR22.
https://t.co/DNKVmPjmh9 https://t.co/b5x26PzzS5
Links:
Dr. John Cush RheumNow ( View Tweet)
Sarilumab in Polymyalgia Rheumatica: Results from SAPHYR Trial
Dr. Michael Putman interviews Dr. Robert Speira about abstract 1676 presented at #ACR22.
https://t.co/nJAOBDC8KX https://t.co/Tgls8O4AVC
Links:
Dr. John Cush RheumNow ( View Tweet)
